Personalizing First-Line Therapy for CLL

Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event

Double-Class Refractory CLL in Community Practice: Current and Future Management

Navigating Treatment Sequencing After Frontline Treatment Failure in CLL

Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice

Progress in Breast Cancer Care: Translating SABCS Data Into Practice

Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event

Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice

From Pixels to Practice: Advancing HCM Care With Multimodality Imaging

From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma

Navigating Treatment Sequencing After Frontline Treatment Failure in CLL

Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors 

Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction

Personalizing First-Line Therapy for CLL

NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors

No Patient with CKD Left Behind! Emerging CKD Therapies in T1D

A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF